Redeye updates its estimates following Pagero’s Q3 2023 report, which was more or less in line on th...
3.5pp q-o-q margin expansion a strong statement Adj.
Redeye updates its estimates and valuation after reviewing Tessin's Q3 report, which showed somewhat...
Redeye is encouraged to see the progress made by Scandinavian ChemoTech in the Q3 2023 report, which...
Seasonal slowdown: Q3e sales SEK 30m, EBIT SEK -4m We expect profitability in '25e: sales SEK 157m, ...
Redeye comments on Alelion’s decision to file for bankruptcy.
Redeye provides an update in relation to Optomed’s Q3 2023 report.
Movinn published on November 3rd the company’s Q3-report for 2023.
Tvåsiffrig negativ organisk tillväxt i kvartalet… Med en acceleration av nedstängningen av kopparnät...
ChargePanel AB (publ) meddelade den 2 november att bolaget har ingått ett samarbete med Charge4Go AB...
Divests the smallest group company Hedén Minor effect on estimates, outlook unaffected Trading at 16...
Minor estimate changes Gross margin improvements still on the horizon '24e lease adj.
Exel’s Q3 headline figures were known beforehand. Volumes fell across the geographic regions and esp...
Continued headwinds in Denmark and Germany in Q3 Underlying '24e-'25e EBITA cut 12-9%, but neutral i...
Redeye updates on W5 Solution following its Q3-results which came in stronger than expected.
Boreo's Q3 2023 net sales of EUR 41m were 6% short of our forecast, while adjusted EBIT ex-PPA of EU...
In light of BankNordik's Q3 report, we raise 2023E-24E adjusted EPS by ~5%.
Q3e sales SEK 61m, up 25% y-o-y, adj. EBITDA SEK -0.
Redeye notes Mendus announcing the publication of three abstracts ahead of presentations at ASH on 1...
Aptahem har nyligen publicerat sin rapport för årets tredje kvartal, vilken i sig inte innehöll någr...
